Camurus AB (CAMRF)
64.22
0.00 (0.00%)
USD |
OTCM |
Dec 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.828B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 26.02% |
| Valuation | |
| PE Ratio | 49.63 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 16.54 |
| Price to Book Value | 8.746 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0258 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 27.76% |
Profile
| Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden. |
| URL | http://www.camurus.com |
| Investor Relations URL | N/A |
| HQ State/Province | Skane |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 12, 2026 |
| Last Earnings Release | Nov. 06, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden. |
| URL | http://www.camurus.com |
| Investor Relations URL | N/A |
| HQ State/Province | Skane |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 12, 2026 |
| Last Earnings Release | Nov. 06, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |